{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:13:02Z","timestamp":1792872782885,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.msard.2026.107330","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:29:03Z","timestamp":1782170943000},"page":"107330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Is serum neurofilament light chain accurate enough to guide multiple sclerosis care? Diagnostic performance and optimal cutoff in a systematic review and meta-analysis"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9508-4938","authenticated-orcid":false,"given":"Jo\u00e3o Lucas Silva","family":"Santana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Martins","family":"Themoteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Abrah\u00e3o","family":"Allioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Alexandre Santos","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique de Moraes","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena Lins","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana Bacelar Limeira","family":"Sales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira Luisa","family":"Ap\u00f3stolos-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarso","family":"Adoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagoberto","family":"Callegaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9764-3763","authenticated-orcid":false,"given":"Guilherme Diogo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2026.107330_bib0003","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40120-022-00427-8","article-title":"Serum neurofilament light trajectories and their relation to subclinical radiological disease activity in relapsing multiple sclerosis patients in the APLIOS trial","volume":"12","author":"Bar-Or","year":"2023","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.msard.2026.107330_bib0034","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awy154","article-title":"Serum neurofilament as a predictor of disease worsening and brain atrophy in multiple sclerosis","volume":"141","author":"Barro","year":"2018","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2026.107330_bib0008","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107330_bib0018","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200167","article-title":"Increasing neurofilament and glial fibrillary acidic protein after treatment discontinuation predicts multiple sclerosis disease activity","volume":"10","author":"Bose","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107330_bib0035","first-page":"1352","article-title":"Combining serum neurofilament light chain and MRI metrics improves prediction of MS disease activity","volume":"27","author":"Cant\u00f3","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107330_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109688","article-title":"Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis","volume":"253","author":"Chitnis","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.msard.2026.107330_bib0037","article-title":"Integrating biomarkers to predict disease evolution in multiple sclerosis","volume":"58","author":"Dalla Costa","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2026.107330_bib0032","first-page":"358","article-title":"Serum neurofilament light chain levels are increased in patients with clinically isolated syndrome and predict conversion to multiple sclerosis","volume":"23","author":"Disanto","year":"2017","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2026.107330_bib0006","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2026.107330_bib0021","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/acn3.70149","article-title":"Serum neurofilament light chain in multiple sclerosis: superiority of age- and BMI-corrected Z scores\/percentiles over absolute cutoff values for prediction of treatment response","volume":"12","author":"Einsiedler","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2026.107330_bib0022","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/medicina59050865","article-title":"Annual plasma neurofilament dynamics is a sensitive biomarker of disease activity in multiple sclerosis","volume":"59","author":"Fedi\u010dov\u00e1","year":"2023","journal-title":"Medicina"},{"key":"10.1016\/j.msard.2026.107330_bib0027","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209357","article-title":"Temporal relationship between serum neurofilament light chain and radiologic disease activity in patients with multiple sclerosis","volume":"102","author":"Fox","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107330_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104970","article-title":"Guidance for use of neurofilament light chain as a CSF and blood biomarker in multiple sclerosis management","volume":"101","author":"Freedman","year":"2024","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.msard.2026.107330_bib0026","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00415-025-13231-9","article-title":"Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS)","volume":"272","author":"Fung","year":"2025","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107330_bib0002","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107330_bib0036","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","article-title":"Plasma concentration of neurofilament light chain protein in HIV infection","volume":"3","author":"Gissl\u00e9n","year":"2016","journal-title":"EBioMedicine"},{"issue":"15","key":"10.1016\/j.msard.2026.107330_bib0005","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.4155\/bio-2019-0163","article-title":"Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood","volume":"11","author":"Hendricks","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.msard.2026.107330_bib0012","doi-asserted-by":"crossref","first-page":"e853","DOI":"10.1016\/S2589-7500(22)00188-1","article-title":"Interpreting area under the receiver operating characteristic curve","volume":"4","author":"Hond","year":"2022","journal-title":"Lancet Digit. Health"},{"issue":"6","key":"10.1016\/j.msard.2026.107330_bib0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/1352458519840757","article-title":"Longitudinal analysis of serum neurofilament light chain: a potential therapeutic monitoring biomarker for multiple sclerosis","volume":"26","author":"Hyun","year":"2020","journal-title":"Mult. Scler."},{"issue":"10422","key":"10.1016\/j.msard.2026.107330_bib0001","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.msard.2026.107330_bib0019","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/13524585241237388","article-title":"Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: a 48-week prospective single-center study","volume":"30","author":"Johnsson","year":"2024","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.msard.2026.107330_bib0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2026.107330_bib0033","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107330_bib0030","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jbi.2005.02.008","article-title":"Ohno-Machado L. The use of ROC curves in biomedical informatics","volume":"38","author":"Lasko","year":"2005","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.msard.2026.107330_bib0017","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","article-title":"Monitoring disease activity in multiple sclerosis using serum neurofilament light protein","volume":"89","author":"Novakova","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107330_bib0016","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.msard.2026.107330_bib0014","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.msard.2026.107330_bib0031","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/aje\/kwj063","article-title":"The inconsistency of \u201coptimal\u201d cutpoints using ROC-based criteria","volume":"163","author":"Perkins","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.msard.2026.107330_bib0010","article-title":"Biomarkers of response to ocrelizumab in relapsing\u2013remitting multiple sclerosis","volume":"15","author":"Rodr\u00edguez-Jorge","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.msard.2026.107330_bib0007","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1177\/13524585211039104","article-title":"Exploring CSF neurofilament light as a biomarker for MS in clinical practice: a retrospective registry-based study","volume":"28","author":"Rosenstein","year":"2022","journal-title":"Mult. Scler. J."},{"issue":"5","key":"10.1016\/j.msard.2026.107330_bib0028","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/1352458518765666","article-title":"Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis","volume":"25","author":"Siller","year":"2019","journal-title":"Mult. Scler."},{"issue":"13","key":"10.1016\/j.msard.2026.107330_bib0023","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1177\/1352458521998039","article-title":"Plasma neurofilament light chain levels are predictors of disease activity in multiple sclerosis as measured by four-domain NEDA status, including brain volume loss","volume":"27","author":"Szilasiov\u00e1","year":"2021","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2026.107330_bib0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.5507\/bp.2021.034","article-title":"Associations between neurofilament light chain levels, disease activity and brain atrophy in progressive multiple sclerosis","volume":"166","author":"Szilasiov\u00e1","year":"2022","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub."},{"issue":"4","key":"10.1016\/j.msard.2026.107330_bib0024","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000515806","article-title":"Neurofilament light chain levels are associated with disease activity determined by no evident disease activity in multiple sclerosis patients","volume":"84","author":"Szilasiov\u00e1","year":"2021","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.msard.2026.107330_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103535","article-title":"High or increasing serum NfL is predictive of impending multiple sclerosis relapses","volume":"59","author":"Thebault","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107330_bib0011","doi-asserted-by":"crossref","first-page":"9147","DOI":"10.1038\/s41598-021-88624-7","article-title":"Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment","volume":"11","author":"Walo-Delgado","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.107330_bib0029","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:33:10Z","timestamp":1783423990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826003664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"alternative-id":["S2211034826003664"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107330","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is serum neurofilament light chain accurate enough to guide multiple sclerosis care? Diagnostic performance and optimal cutoff in a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107330"}}